GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

10368	Companies
215969	Keywords
145712	Articles
114376	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 05/20/2025 at 22:10, 11 months 18 days ago

GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
GENFIT to receive a €26.5 million milestone payment for pricing approval of Ipsen's Iqirvo® in Italy. This unlocks a new phase for pipeline progress in liver diseases

Approval GENFIT Milestone Payment Ipsen Iqirvo®
PRESS RELEASE

published on 05/20/2025 at 22:10, 11 months 18 days ago

GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie
GENFIT va recevoir un paiement d'étape de 26,5 millions d'euros suite à l'approbation d'Iqirvo® par Ipsen en Italie pour le traitement de la cholangite biliaire primitive

Approbation GENFIT Paiement D'étape Ipsen Iqirvo®
BRIEF

published on 05/14/2025 at 22:15, 11 months 24 days ago

GENFIT Releases 2025 Extra-Financial Performance Report for 2024

Sustainability ESG Biopharmaceutical Corporate Responsibility GENFIT
BRIEF

published on 05/14/2025 at 22:15, 11 months 24 days ago

GENFIT publie son rapport de performance extra-financière 2025 pour 2024

ESG Biopharmaceutique Durabilité Responsabilité D'entreprise GENFIT
PRESS RELEASE

published on 05/14/2025 at 22:10, 11 months 24 days ago

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
GENFIT publishes 2025 Extra-Financial Performance Report for fiscal year 2024. Focus on sustainability, ESG approach, social responsibility commitment, and liver disease research

Sustainability GENFIT ESG Approach 2025 Extra-Financial Performance Report Liver Disease Research
BRIEF

published on 05/07/2025 at 22:15, 1 year ago

GENFIT prépare son Assemblée Générale Mixte de juin 2025

Assemblée Générale Biopharmaceutique Documentation GENFIT Vote En Ligne
BRIEF

published on 05/07/2025 at 22:15, 1 year ago

GENFIT prepares its Combined General Meeting in June 2025

Biopharmaceuticals General Assembly Documentation GENFIT Online Voting
PRESS RELEASE

published on 05/07/2025 at 22:10, 1 year ago

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
GENFIT announces Annual Combined General Meeting on June 17, 2025, providing shareholders with preparatory documents and online voting option. Company's focus on liver diseases and diverse R&D portfolio highlighted

Shareholders Annual Meeting Liver Diseases GENFIT R&D Portfolio
PRESS RELEASE

published on 05/07/2025 at 22:10, 1 year ago

GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires
GENFIT annonce l'Assemblée Générale Mixte du 17 juin 2025 et la mise à disposition des documents préparatoires. Retransmission en ligne et vote par Internet disponibles

Assemblée Générale Biopharmaceutique Documents Préparatoires GENFIT Vote En Ligne
BRIEF

published on 05/05/2025 at 07:35, 1 year ago

GENFIT to Showcase ACLF Research at EASL Congress 2025

Biopharmaceutical GENFIT EASL Congress ACLF Research Hepatology

Accesswire

Published on 05/08/2026 at 01:50, 1 hour 43 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 2 hours 48 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 3 hours 33 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 4 hours 3 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 4 hours 18 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 23:23, 4 hours 9 minutes ago

H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 4 hours 18 minutes ago

EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 5 hours 28 minutes ago

Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 6 hours 50 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 8 hours 47 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/07/2026 at 19:15, 8 hours 18 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 8 hours 18 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 8 hours 27 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 8 hours 27 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 8 hours 33 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE